Polylactic acid microsphere, preparation method thereof and application of polylactic acid microsphere in facial filler
By using high-speed shearing and vacuum freeze-drying technology in the preparation of polylactic acid microspheres, combined with surfactant and defoaming agent, the problems of uneven particle size and unstable morphology of polylactic acid microspheres have been solved, and the microspheres have been significantly improved. Mechanical strength and biocompatibility reduce adverse reactions after injection.
Patent Information
- Application Number
- CN202411130906.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing polylactic acid microspheres are prepared in complex and have poor controllability in particle size, resulting in uneven particle size and unstable morphology of the microspheres, resulting in adverse reactions such as subcutaneous nodules or redness and swelling.
Use polylactic acid to dissolve dichloromethane, mix polyvinyl alcohol solution and defoaming agent to perform high-speed shearing under ice bath conditions, add surfactant, and then distillate under reduced pressure and freeze-drying to form a uniform and dense poly Lactate microspheres.
Polylactic acid microspheres with uniform particle size and smooth surface were obtained, which improved mechanical strength and drug release performance, reduced inflammatory responses in facial tissues after injection, and significantly reduced the occurrence of adverse reactions.
Smart Images

Figure BDA0004997780390000121 
Figure BDA0004997780390000131
Abstract
Description
Technical Field
[0001] The present application relates to the field of biomedical technology, and in particular to polylactic acid microspheres, a preparation method thereof, and an application thereof in facial fillers. Background Art
[0002] Facial fillers are mainly used to improve facial soft tissue defects, static wrinkles on the skin, and tissue contours. As a new type of biodegradable material, polylactic acid is a highly hydrophobic substance, with poor adhesion to cells and the formation of lactic acid, a degradation product. In the early stages of injection of polylactic acid products, a mild inflammatory reaction will occur on the face. Unlike other fillers, polylactic acid, as an excitatory filler, can stimulate fibroblasts and other cells to secrete collagen after injection to achieve a cosmetic effect. Although the therapeutic effect will only appear after several months, it can last up to 3 years in the tissue.
[0003] Since the degradation half-life of polylactic acid in saline is about 20 weeks, in order to inhibit its degradation, the polylactic acid injections currently approved on the market are in the form of microspheres or microparticles. However, the preparation process of existing polylactic acid microspheres or microparticles is complicated, the particle size controllability is poor, and the formed microspheres have uneven particle sizes and unstable shapes, which can cause adverse reactions such as subcutaneous nodules or redness and swelling. Summary of the invention
[0004] In order to provide a polylactic acid microsphere with uniform particle size and stable shape, which is easy to disperse and has less adverse reactions when used as a facial filler, the present application provides a polylactic acid microsphere, a preparation method thereof and its application in a facial filler.
[0005] The present application provides a method for preparing polylactic acid microspheres and their application in facial fillers, using the following technical solutions:
[0006] A method for preparing polylactic acid microspheres comprises the following steps:
[0007] Adding polylactic acid into dichloromethane, stirring and dissolving to obtain solution A;
[0008] Add polyvinyl alcohol to water, stir to dissolve, and obtain a polyvinyl alcohol solution; add an appropriate amount of defoaming agent to the polyvinyl alcohol solution, and mix well to obtain a solution B;
[0009] Solution A and solution B are mixed, high-speed shearing is performed under ice bath conditions, a surfactant is added, and the mixture is stirred at 400-600 rpm for 4-10 hours. Dichloromethane is removed by vacuum distillation, and the mixture is centrifuged and rinsed to obtain a powder. The powder is vacuum freeze-dried at -40-(-80)°C for 26-30 hours and sieved to obtain polylactic acid microspheres.
[0010] By adopting the above technical scheme, the polylactic acid solution and the polyvinyl alcohol solution are subjected to high-speed shearing under ice bath conditions to obtain an emulsion; the emulsion is mixed with water, and after removing the solvent, the polylactic acid microspheres are obtained after vacuum freeze drying; during the preparation process, a defoaming agent is added to effectively inhibit and eliminate the foam generated by polyvinyl alcohol, so that the solution is more uniform and stable, which is conducive to forming a uniform and dense polylactic acid microsphere structure; by adding a surfactant, the interfacial tension between the two solutions can be significantly reduced, and the formation of the emulsion is promoted, thereby obtaining uniform and fine polylactic acid microspheres. The above preparation method helps to improve the mechanical strength, stability and drug release performance of the microspheres, and the obtained microspheres have a smooth surface, uniform particle size, and are easy to inject.
[0011] Preferably, the polylactic acid is one of dextrorotatory polylactic acid, levorotatory polylactic acid, mesorotatory polylactic acid and racemic polylactic acid; and the concentration of solution A is 20-30%.
[0012] Preferably, the concentration of the polyvinyl alcohol solution is 8-12%.
[0013] Preferably, the volume ratio of solution A to solution B is 1:3-7.
[0014] Preferably, the surfactant is a mixture of Tween-80 and sophorolipids, and the mass ratio of the two is 1:0.6-1.
[0015] By adopting the above technical scheme, a mixture of Tween-80 and sophorolipids is used as a surfactant, which not only has the properties of conventional surfactants such as solubilization, emulsification, and wetting, and is conducive to obtaining polylactic acid microspheres with smooth surface and uniform particle size, but also has biocompatibility, as well as biological activities such as antibacterial and antiviral, which can reduce the inflammatory response of facial tissues after injection, help shorten the recovery time, and reduce the discomfort of patients.
[0016] Preferably, the added amount of the surfactant is 0.5-1% of the total volume of solution A and solution B.
[0017] Preferably, the defoaming agent is ricinoleamine.
[0018] By adopting the above technical scheme, using ricinoleamine as a defoaming agent not only has the conventional defoaming and foam suppression functions, but also ricinoleamine is relatively safe and less irritating, and has excellent biocompatibility, which is beneficial to reducing the inflammatory response of facial tissues after injection, helping to shorten the recovery time and reduce the discomfort of patients.
[0019] The present application provides a polylactic acid microsphere, which adopts the following technical solution:
[0020] A method for preparing polylactic acid microspheres provides polylactic acid microspheres.
[0021] The application of polylactic acid microspheres in facial fillers provided in this application adopts the following technical solution:
[0022] The invention discloses an application of polylactic acid microspheres in a facial filler. The raw materials of the facial filler include 40-60% of polylactic acid microspheres, 20-40% of sodium carboxymethyl cellulose and 15-30% of mannitol by mass percentage.
[0023] By adopting the above technical scheme, polylactic acid microspheres are compounded with sodium carboxymethyl cellulose and mannitol as facial fillers. The polylactic acid microspheres provide a long-lasting filling effect, mannitol provides moisturizing, anti-inflammatory and collagen synthesis promotion functions, and sodium carboxymethyl cellulose enhances the stability of the filler and promotes drug absorption. The obtained facial filler can not only significantly improve the overall effect of facial filling, making the skin fuller, firmer and more elastic, but also has good biocompatibility and safety, and can reduce the occurrence of side effects after injection such as redness, swelling, pain, allergies and other reactions.
[0024] Preferably, the method for preparing the facial filler comprises the following steps:
[0025] The polylactic acid microspheres, sodium carboxymethyl cellulose and mannitol are uniformly mixed to obtain a mixed solution, which is half-stoppered after filling, and then vacuum-freeze-dried, plugged, capped and packaged to obtain a facial filler.
[0026] In summary, the present application includes at least one of the following beneficial technical effects:
[0027] 1. The preparation method of polylactic acid microspheres provided in the present application helps to improve the mechanical strength, stability and drug release performance of the microspheres, and the obtained microspheres have a smooth surface, uniform particle size and are easy to inject;
[0028] 2. In the preparation method of polylactic acid microspheres provided in the present application, a defoaming agent is added to effectively inhibit and eliminate the foam generated by polyvinyl alcohol, so that the solution is more uniform and stable, which is conducive to the formation of a uniform and dense polylactic acid microsphere structure; by adding a surfactant, the interfacial tension between the two solutions can be significantly reduced, and the formation of an emulsion is promoted, thereby obtaining uniform and fine polylactic acid microspheres;
[0029] 3. The present application adopts a compound of polylactic acid microspheres with sodium carboxymethyl cellulose and mannitol as a facial filler, which can not only significantly improve the overall effect of facial filling, making the skin fuller, firmer and more elastic, but also has good biocompatibility and safety, and can reduce the occurrence of side effects after injection such as redness, swelling, pain, allergies and other reactions. DETAILED DESCRIPTION
[0030] The present application is further described in detail below in conjunction with embodiments.
[0031] Example 1
[0032] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0033] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0034] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 2 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipid is 1:0.6.
[0035] Example 2
[0036] S1. Add dextrorotatory polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 25%;
[0037] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 10%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well, and obtain a solution B;
[0038] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 3000 rpm for 7 min, and then 2 mL of surfactant was added, and stirred at 500 rpm for 7 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -60 ° C for 28 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipids was 1:0.6.
[0039] Example 3
[0040] S1. Add racemic polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 30%;
[0041] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 12%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well, and obtain a solution B;
[0042] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 4000 rpm for 10 min, and then 2 mL of surfactant was added, and stirred at 600 rpm for 10 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -80 ° C for 26 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipid is 1:0.6.
[0043] Example 4
[0044] S1. adding meso-polylactic acid to dichloromethane and stirring to dissolve to obtain a solution A having a concentration of 20%;
[0045] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0046] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 5000 rpm for 4 min, and then 2 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipids was 1:0.6.
[0047] Example 5
[0048] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0049] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0050] S3. 100 mL of solution A and 500 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 3 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipids was 1:0.6.
[0051] Example 6
[0052] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0053] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0054] S3. 100 mL of solution A and 700 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 4 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipids was 1:0.6.
[0055] Example 7
[0056] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0057] S2. Add polyvinyl alcohol to water, stir to dissolve, and obtain a polyvinyl alcohol solution having a concentration of 8%. Add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well, and obtain a solution B;
[0058] S3. 100 mL of solution A and 100 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 1 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; the mass ratio of surfactant Tween-80 to sophorolipid in this embodiment is 1:0.6.
[0059] Example 8
[0060] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0061] S2. Add polyvinyl alcohol to water, stir to dissolve, and obtain a polyvinyl alcohol solution having a concentration of 8%. Add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well, and obtain a solution B;
[0062] S3. 100 mL of solution A and 900 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 5 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of surfactant Tween-80 to sophorolipids was 1:0.6.
[0063] Example 9
[0064] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0065] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0066] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 2.8 mL of a surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain a powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of the surfactant Tween-80 to the sophorolipid was 1:0.6.
[0067] Example 10
[0068] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0069] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0070] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 4 mL of surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; the mass ratio of surfactant Tween-80 to sophorolipid in this embodiment is 1:0.6.
[0071] Embodiment 11
[0072] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0073] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0074] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 1.2 mL of a surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain a powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of the surfactant Tween-80 to the sophorolipid was 1:0.6.
[0075] Example 12
[0076] S1. Add L-polylactic acid to dichloromethane and stir to dissolve to obtain a solution A having a concentration of 20%;
[0077] S2. Add polyvinyl alcohol to water, stir and dissolve to obtain a polyvinyl alcohol solution having a concentration of 8%, add an appropriate amount of defoaming agent castor oil amine to the polyvinyl alcohol solution, mix well to obtain a solution B;
[0078] S3. 100 mL of solution A and 300 mL of solution B were mixed, and high-speed shearing was performed in an ice bath at 2000 rpm for 5 min, and then 4.8 mL of a surfactant was added, and stirred at 400 rpm for 4 h. After removing dichloromethane by reduced pressure distillation, centrifugation and washing were performed to obtain a powder. The powder was vacuum freeze-dried at -40 ° C for 30 h, and then sieved to obtain polylactic acid microspheres; in this embodiment, the mass ratio of the surfactant Tween-80 to the sophorolipid was 1:0.6.
[0079] Example 13
[0080] The difference between Example 13 and Example 1 is that the mass ratio of the surfactant Tween-80 to the sophorolipid used in Example 13 is 1:0.8.
[0081] Embodiment 14
[0082] The difference between Example 14 and Example 1 is that the mass ratio of the surfactant Tween-80 to the sophorolipid used in Example 14 is 1:1.
[0083] Embodiment 15
[0084] The difference between Example 15 and Example 1 is that the mass ratio of the surfactant Tween-80 to the sophorolipid used in Example 15 is 1:0.4.
[0085] Example 16
[0086] The difference between Example 16 and Example 1 is that the mass ratio of the surfactant Tween-80 to the sophorolipid used in Example 16 is 1:1.2.
[0087] Comparative Example 1
[0088] The difference between Comparative Example 1 and Example 1 is that no defoaming agent is added in Comparative Example 1.
[0089] Comparative Example 2
[0090] The difference between Comparative Example 2 and Example 1 is that no surfactant is added in Comparative Example 1.
[0091] Application Example 1
[0092] 40 g of the polylactic acid microspheres prepared in Example 1, 40 g of sodium carboxymethyl cellulose and 20 g of mannitol were uniformly mixed to obtain a mixed solution, which was half-stoppered after filling, vacuum freeze-dried and plugged, and then rolled and packaged to obtain a facial filler.
[0093] Application Example 2
[0094] 50 g of the polylactic acid microspheres prepared in Example 1, 20 g of sodium carboxymethyl cellulose and 30 g of mannitol were uniformly mixed to obtain a mixed solution, which was half-stoppered after filling, vacuum freeze-dried and plugged, and then rolled and packaged to obtain a facial filler.
[0095] Application Example 3
[0096] 60 g of the polylactic acid microspheres prepared in Example 1, 25 g of sodium carboxymethyl cellulose and 15 g of mannitol were uniformly mixed to obtain a mixed solution, which was half-stoppered after filling, vacuum freeze-dried and plugged, and then rolled and packaged to obtain a facial filler.
[0097] Application Example 4-18
[0098] The difference between Application Example 4-18 and Application Example 1 is that the polylactic acid microspheres in Application Example 4-18 are from Example 2-16.
[0099] Comparative Application Example 1-2
[0100] The difference between Comparative Application Example 1-2 and Application Example 1 is that the polylactic acid microspheres in Comparative Application Example 1-2 come from Comparative Example 1-2.
[0101] Performance testing
[0102] The facial fillers prepared in Application Examples 1-18 and Comparative Application Examples 1-2 were reconstituted with physiological saline and then injected into the skin of guinea pigs for a filler experiment. Specifically, 200 guinea pigs were divided into 20 groups, with 10 in each group, and 4 guinea pigs were injected into each application example as a parallel control.
[0103] The injection method is as follows: After re-dissolving the facial fillers prepared in Application Examples 1-18 and Comparative Application Examples 1-2 with physiological saline, 0.2 mL is taken and implanted into the back skin of guinea pigs, and whether there are adverse reactions such as redness, swelling, and subcutaneous nodules after three days, one week, and one month. The reactions of the polylactic acid microspheres of each example after injection are shown in Table 1.
[0104] The specific test results are as follows:
[0105] Table 1 Performance test results
[0106]
[0107]
[0108] It can be seen from the test results in Table 1 that the polylactic acid microspheres and the preparation method thereof, as well as the preparation of the facial filler provided by the present application, can easily disperse the obtained facial filler and have fewer adverse reactions.
[0109] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.
Claims
1. A method for preparing polylactic acid microspheres, characterized in that: The following steps are involved: Adding polylactic acid into dichloromethane, stirring and dissolving to obtain solution A; Add polyvinyl alcohol to water, stir to dissolve, and obtain a polyvinyl alcohol solution; add an appropriate amount of defoaming agent to the polyvinyl alcohol solution, and mix well to obtain a solution B; Solution A and solution B are mixed, high-speed shearing is performed under ice bath conditions, a surfactant is added, and the mixture is stirred at 400-600 rpm for 4-10 hours. Dichloromethane is removed by vacuum distillation, and the mixture is centrifuged and rinsed to obtain a powder. The powder is vacuum freeze-dried at -40-(-80)°C for 26-30 hours and sieved to obtain polylactic acid microspheres.
2. The method for preparing polylactic acid microspheres according to claim 1, characterized in that: The polylactic acid is one of dextrorotatory polylactic acid, levorotatory polylactic acid, mesorotatory polylactic acid and racemic polylactic acid; the concentration of the solution A is 20-30%.
3. The method for preparing polylactic acid microspheres according to claim 1, characterized in that: The concentration of the polyvinyl alcohol solution is 8-12%.
4. A method for preparing polylactic acid microspheres according to claim 1, 2 or 3, characterized in that: The volume ratio of solution A to solution B is 1:3-7.
5. The method for preparing polylactic acid microspheres according to claim 1, characterized in that: The surfactant is a mixture of Tween-80 and sophorolipids, and the mass ratio of the two is 1:0.6-1.
6. A method for preparing polylactic acid microspheres according to claim 1 or 5, characterized in that: The added amount of the surfactant is 0.5-1% of the total volume of solution A and solution B.
7. The method for preparing polylactic acid microspheres according to claim 1, characterized in that: The defoaming agent is ricinoleamine.
8. Polylactic acid microspheres prepared by the method for preparing polylactic acid microspheres according to any one of claims 1 to 7.
9. The use of polylactic acid microspheres as claimed in claim 8 in facial fillers, characterized in that: The facial filler raw materials include 40-60% polylactic acid microspheres, 20-40% sodium carboxymethyl cellulose, and 15-30% mannitol by mass percentage.
10. The polylactic acid microspheres and the use thereof in facial fillers according to claim 9, characterized in that: The preparation method of the facial filler comprises the following steps: The polylactic acid microspheres, sodium carboxymethyl cellulose and mannitol are uniformly mixed to obtain a mixed solution, which is half-stoppered after filling, and then vacuum-freeze-dried, plugged, capped and packaged to obtain a facial filler.
Citation Information
Patent Citations
Skin filler used for injection and preparing method and application thereof
CN105749359A
Composition for skin filling and preparation method thereof
CN108619564A
Triazolone-difenoconazole polylactic acid microsphere and preparation method thereof
CN109197876A
Polylactic acid microspheres and preparation method and application thereof
CN110051882A
Antineoplasma medicine pidorubicin slow release microsphere preparation and method for preparing same
CN1927183A
Cited By
L-polylactic acid microsphere filler for improving redissolution injection and preparation method of L-polylactic acid microsphere filler
CN119770745A
Polylactic acid skin filler and preparation method thereof
CN121338096A
